Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

What's the Outlook for Novavax Stock?

TheMotleyFool

0 0

Shares of Novavax (NASDAQ: NVAX) have retreated from their recent peaks, but this biotech stock is still up over 2,610% in 2020, and investors want to know if it can jump higher once again.

On one hand, investors are right to be worried about the future of any 33-year-old vaccine developer that hasn't produced any successful vaccines yet. That said, governments around the world are supporting the development of Novavax's experimental coronavirus vaccine.

Image source: Getty Images.

Source Fool.com

Like: 0

NVAX

Share